Adipocyte-specific deletion of Tcf7l2 induces dysregulated lipid metabolism and impairs glucose tolerance in mice
Year: 2020
Type: article
Abstract: AIMS/HYPOTHESIS: Transcription factor 7-like 2 (TCF7L2) is a downstream effector of the Wnt/β-catenin signalling pathway implicated in type 2 diabetes risk through genome-wide association studies. Although its expression is critical for adipocyte development, the potential roles of changes in adipose tissue TCF7L2 levels in diabetes risk are poorly defined. Here, we investigated whether forced changes in Tcf7l2 expression in adipocytes affect whole body glucose or lipid metabolism and crosstalk between disease-relevant tissues. METHODS: Tcf7l2 was selectively ablated in mature adipocytes in C57BL/6J mice using Cre recombinase under Adipoq promoter control to recombine Tcf7l2 alleles floxed at exon 1 (referred to as aTCF7L2 mice). aTCF7L2 mice were fed normal chow or a high-fat diet for 12 weeks. Glucose and insulin sensitivity, as well as beta cell function, were assessed in vivo and in vitro. Levels of circulating NEFA, selected hormones and adipokines were measured using standard assays. RESULTS: Reduced TCF7L2 expression in adipocytes altered glucose tolerance and insulin secretion in male but not in female mice. Thus, on a normal chow diet, male heterozygote knockout mice (aTCF7L2het) exhibited impaired glucose tolerance at 16 weeks (p = 0.03) and increased fat mass (1.4 ± 0.1-fold, p = 0.007) but no changes in insulin secretion. In contrast, male homozygote knockout (aTCF7L2hom) mice displayed normal body weight but impaired oral glucose tolerance at 16 weeks (p = 0.0001). These changes were mechanistically associated with impaired in vitro glucose-stimulated insulin secretion (decreased 0.5 ± 0.1-fold vs control mice, p = 0.02) and decreased levels of the incretins glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide (0.6 ± 0.1-fold and 0.4 ± 0.1-fold vs control mice, p = 0.04 and p < 0.0001, respectively). Circulating levels of plasma NEFA and fatty acid binding protein 4 were increased by 1.3 ± 0.1-fold and 1.8 ± 0.3-fold vs control mice (p = 0.03 and p = 0.05, respectively). Following exposure to a high-fat diet for 12 weeks, male aTCF7L2hom mice exhibited reduced in vivo glucose-stimulated insulin secretion (0.5 ± 0.1-fold vs control mice, p = 0.02). CONCLUSIONS/INTERPRETATION: Loss of Tcf7l2 gene expression selectively in adipocytes leads to a sexually dimorphic phenotype, with impairments not only in adipocytes, but also in pancreatic islet and enteroendocrine cells in male mice only. Our findings suggest novel roles for adipokines and incretins in the effects of diabetes-associated variants in TCF7L2, and further illuminate the roles of TCF7L2 in glucose homeostasis and diabetes risk. Graphical abstract.
Source: Diabetologia
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,480
Funders: Eli Lilly and Company, Wellcome Trust, European Federation of Pharmaceutical Industries and Associations, National Institute for Health and Care Research, Diabetes UK, Society for Endocrinology, Academy of Medical Sciences, Imperial College London, European Commission, Rosetrees Trust, European Foundation for the Study of Diabetes, European Association for the Study of Diabetes, Innovative Medicines Initiative, Horizon 2020 Framework Programme, Medical Research Council, Biotechnology and Biological Sciences Research Council
Awards: G130968091, G1335979935, G1635243398, Genetic and nutritional control of pancreatic beta cell identity., G1937207371, Roles of GWA genes in controlling pancreatic beta cell function and mass., G2040450235, Control of glucagon secretion by AMPK and related kinases., G2400843396, G3346581055, G3460133382, G3522604332, Role of mitochondrial calcium transport in the regulation of insulin secretion, G3555667338, G434337789, Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881, G4426574518, AMPK-mediated regulation and roles of miR-125b and miR-184 in pancreatic beta-cell function., G4781795914, All-optical deconstruction of the islet wiring patterns underlying insulin secretion in health and disease, Ligand bias at the GLP-1 receptor as a means of favouring cytoprotection, G5482254092, G5485930741, Targeting etiologic molecular mechanisms to treat human diabetes, G5673545276, G5675939615, G5877155211, The impact of long non-coding RNA at the Pax6 locus on beta cell identity and function, G6133425169, Defining the molecular and physiological mechanisms of pancreatic islet dysfunction which lead to type 2 diabetes, Role and regulation of GLP-1 receptor trafficking in pancreatic beta cells, Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes, G6693145033, Coordination and Advancement of sub-Saharan Africa-EU Science & Technology Cooperation Network, G7005210393, Understanding pancreatic beta cell connectivity, Molecular mechanisms linking Sorcin to pancreatic beta cell lipotoxicity and ER Ca2+ stores., G7328074751, Determining the role of arcuate nucleus glucokinase in the regulation of glucose homeostasis, G7571465722, Roles of the type 2 diabetes (T2D)-associated gene C2cd4a in regulating glucose homeostasis in the mouse, G8635620823, G8897119323, G9000168923
OpenAlex ID: W3093018380